Sialadenosis classification

Sialadenosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Sialadenosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Guidelines for Management

Case Studies

Case #1

Sialadenosis classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sialadenosis classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sialadenosis classification

CDC on Sialadenosis classification

Sialadenosis classification in the news

Blogs on Sialadenosis classification

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Sialadenosis classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Mahda Alihashemi M.D. [2]

## Overview

[edit | edit source]

There is no established system for the classification of [disease name].

[Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4].

[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3]. [Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].

Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.

If the staging system involves specific and characteristic findings and features: According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].

The staging of [malignancy name] is based on the [staging system].

There is no established system for the staging of [malignancy name].

## Classification

[edit | edit source]

* There is no established system for the classification of [disease name].

* [Disease name] may be classified according to [classification method] into [number] subtypes/groups:
* [Group1]
* [Group2]
* [Group3]
* [Group4]

* [Disease name] may be classified into [large number > 6] subtypes based on:
* [Classification method 1]
* [Classification method 2]
* [Classification method 3]
* [Disease name] may be classified into several subtypes based on:
* [Classification method 1]
* [Classification method 2]
* [Classification method 3]

* Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.

* If the staging system involves specific and characteristic findings and features:
* According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].

* The staging of [malignancy name] is based on the [staging system].

* There is no established system for the staging of [malignancy name].

## References

[edit | edit source]

Template:WH Template:WS